Angioedema and maculopapular eruptions associated with carbamazepine administration

CNS Spectrums

Volumn 11, Issue 5, 2006, Pages 352-354

  Elias, Alby ^a   Madhusoodanan, Subramoniam ^b,c   Pudukkadan, David ^d   Antony, James T ^e  

^a Department of Psychiatry   (India)

^b ST JOHN S EPISCOPAL HOSPITAL   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d Jubilee Medical College

^e Jubilee Mission Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BRADYKININ; CARBAMAZEPINE; CLONAZEPAM; HYDROXYZINE; IMMUNOGLOBULIN E; LITHIUM; RISPERIDONE; VALPROIC ACID;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; DISEASE SEVERITY; DIZZINESS; DRUG WITHDRAWAL; EYELID EDEMA; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOCYTE COUNT; MACULOPAPULAR RASH; MANIA; MOOD DISORDER; PATIENT MONITORING; PRIORITY JOURNAL; PRURITUS; SKIN DISCOLORATION; SODIUM BLOOD LEVEL; SYNCOPE; TREATMENT RESPONSE; VOMITING;

EID: 33646594150     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900014474     Document Type: Article

References (13)

1. Bigby M. Rates of cutaneous reactions to drugs. Arch Demtatol. 2001;137:765-770.
2. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA. 1986;256:3358-3363.
3. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20 year survey. Allergy. 1997;52:388-393.
4. Swanbeck G, Dahlberg E. Cutaneous drug reactions. An attempt to quantitative estimation. Arch Dermatol Res. 1992;284:215-218.
5. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272-1285.
6. Special Report. Recognition and early warning signs of severe drug-induced cutaneous adverse reactions. Sponsored by The John Hopkins University School of Medicine. Date of original release: March 2005.
7. Syn WK, Naisbitt DJ, Holt AP, et al. Carbamazepine-induced acute liver failure as part of the DRESS syndrome. Int J Clin Pract. 2005;59:988-991.
8. Kaneko K, Igarashi J, Suzuki Y, Niijima S, Ishimoto K, Yabuta K. Carbamazepine-induced thrombocytopenia and leucopenia complicated by Henoch-Schonlein purpura symptoms. Eur J Pediatr. 1993;152:769-770.
9. Harmon RR. Carbamazepine (Tegretol) drug eruptions. Br J Demtatol. 1967;79:500-501.
10. Roberts DL, Marks R. Skin reactions to carbamazepine. Arch Dermatol. 1981;117:273-275.
11. Wintroub BU, Stern RS. Cutaneous drug reactions. In: Fauci AS, Braunwald E, Isselbacher K, et al. eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill: 1998:304-310.
12. Dodds N, Sinert R. Angioedema. Emedicine Web site. Available at: http://www. emedicine.com/emerg/topic32.htm. Accessed November 13, 2005.
13. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997;49:542-546.